These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

699 related items for PubMed ID: 12826316

  • 1. Randomized, multicenter, phase II study of gemcitabine plus cisplatin versus gemcitabine plus carboplatin in patients with advanced non-small cell lung cancer.
    Mazzanti P, Massacesi C, Rocchi MB, Mattioli R, Lippe P, Trivisonne R, Buzzi F, De Signoribus G, Tuveri G, Rossi G, Di Lullo L, Sturba F, Morale D, Catanzani S, Pilone A, Bonsignori M, Battelli T.
    Lung Cancer; 2003 Jul; 41(1):81-9. PubMed ID: 12826316
    [Abstract] [Full Text] [Related]

  • 2. Gemcitabine plus cisplatin vs. gemcitabine plus carboplatin in stage IIIb and IV non-small cell lung cancer: a phase III randomized trial.
    Zatloukal P, Petruzelka L, Zemanová M, Kolek V, Skricková J, Pesek M, Fojtů H, Grygárková I, Sixtová D, Roubec J, Horenková E, Havel L, Průsa P, Nováková L, Skácel T, Kůta M.
    Lung Cancer; 2003 Sep; 41(3):321-31. PubMed ID: 12928123
    [Abstract] [Full Text] [Related]

  • 3. Randomized phase II study comparing weekly docetaxel-cisplatin vs. gemcitabine-cisplatin in elderly or poor performance status patients with advanced non-small cell lung cancer.
    Jang J, Kim HK, Cho BC, Lee KH, Yun HJ, Woo IS, Song HS, Ryoo HM, Kim CH, Sun DS, Shin JW.
    Cancer Chemother Pharmacol; 2017 May; 79(5):873-880. PubMed ID: 28341958
    [Abstract] [Full Text] [Related]

  • 4. Randomized multicentric phase II study of carboplatin/gemcitabine and cisplatin/vinorelbine in advanced non-small cell lung cancer GFPC 99-01 study (Groupe français de pneumo-cancérologie).
    Thomas P, Robinet G, Gouva S, Fournel P, Léna H, Le Caer H, Perol M, Berard H, Bombaron P, Vergnenegre A, Kleisbauer JP, Groupe français de pneumo-cancérologie.
    Lung Cancer; 2006 Jan; 51(1):105-14. PubMed ID: 16310886
    [Abstract] [Full Text] [Related]

  • 5. Phase III trial of gemcitabine and carboplatin versus mitomycin, ifosfamide, and cisplatin or mitomycin, vinblastine, and cisplatin in patients with advanced nonsmall cell lung carcinoma.
    Danson S, Middleton MR, O'Byrne KJ, Clemons M, Ranson M, Hassan J, Anderson H, Burt PA, Fairve-Finn C, Stout R, Dowd I, Ashcroft L, Beresford C, Thatcher N.
    Cancer; 2003 Aug 01; 98(3):542-53. PubMed ID: 12879472
    [Abstract] [Full Text] [Related]

  • 6. Prospective randomized study of four novel chemotherapy regimens in patients with advanced nonsmall cell lung carcinoma: a minnie pearl cancer research network trial.
    Greco FA, Gray JR, Thompson DS, Burris HA, Erland JB, Barton JH, Litchy S, Houston GA, Butts JA, Webb C, Scott C, Hainsworth JD.
    Cancer; 2002 Sep 15; 95(6):1279-85. PubMed ID: 12216096
    [Abstract] [Full Text] [Related]

  • 7. Gemcitabine and low dose carboplatin in the treatment of elderly patients with advanced non-small cell lung cancer.
    Maestu I, Gómez-Aldaraví L, Torregrosa MD, Camps C, Llorca C, Bosch C, Gómez J, Giner V, Oltra A, Albert A.
    Lung Cancer; 2003 Dec 15; 42(3):345-54. PubMed ID: 14644523
    [Abstract] [Full Text] [Related]

  • 8. Randomized phase III study of cisplatin plus irinotecan versus carboplatin plus paclitaxel, cisplatin plus gemcitabine, and cisplatin plus vinorelbine for advanced non-small-cell lung cancer: Four-Arm Cooperative Study in Japan.
    Ohe Y, Ohashi Y, Kubota K, Tamura T, Nakagawa K, Negoro S, Nishiwaki Y, Saijo N, Ariyoshi Y, Fukuoka M.
    Ann Oncol; 2007 Feb 15; 18(2):317-23. PubMed ID: 17079694
    [Abstract] [Full Text] [Related]

  • 9. Gemcitabine plus cisplatin versus gemcitabine plus carboplatin as first-line chemotherapy in advanced transitional cell carcinoma of the urothelium: results of a randomized phase 2 trial.
    Dogliotti L, Cartenì G, Siena S, Bertetto O, Martoni A, Bono A, Amadori D, Onat H, Marini L.
    Eur Urol; 2007 Jul 15; 52(1):134-41. PubMed ID: 17207911
    [Abstract] [Full Text] [Related]

  • 10. A randomized phase II trial of cisplatin plus gemcitabine versus carboplatin plus gemcitabine in patients with completely resected non-small cell lung cancer: Hokkaido Lung Cancer Clinical Study Group Trial (HOT0703).
    Fukumoto SI, Oizumi S, Harada M, Sukoh N, Nakano K, Fuke S, Sakakibara-Konishi J, Takamura K, Ito K, Fujita Y, Nishigaki Y, Harada T, Akie K, Kinoshita I, Amano T, Isobe H, Dosaka-Akita H, Nishimura M, Hokkaido Lung Cancer Clinical Study Group.
    Cancer Chemother Pharmacol; 2020 Jul 15; 86(1):117-127. PubMed ID: 32564128
    [Abstract] [Full Text] [Related]

  • 11. A randomized, phase III multicenter trial of gemcitabine in combination with carboplatin or paclitaxel versus paclitaxel plus carboplatin in patients with advanced or metastatic non-small-cell lung cancer.
    Treat JA, Gonin R, Socinski MA, Edelman MJ, Catalano RB, Marinucci DM, Ansari R, Gillenwater HH, Rowland KM, Comis RL, Obasaju CK, Belani CP, Alpha Oncology Research Network.
    Ann Oncol; 2010 Mar 15; 21(3):540-547. PubMed ID: 19833819
    [Abstract] [Full Text] [Related]

  • 12. The use of gemcitabine in non-small-cell lung cancer. Provincial Lung Cancer Disease Site Group. Provincial Systemic Treatment Disease Site Group.
    Evans WK, Kocha W, Gagliardi A, Eady A, Newman TE.
    Cancer Prev Control; 1999 Feb 15; 3(1):84-94. PubMed ID: 10474757
    [Abstract] [Full Text] [Related]

  • 13. Randomized phase II trial of gemcitabine-cisplatin with or without trastuzumab in HER2-positive non-small-cell lung cancer.
    Gatzemeier U, Groth G, Butts C, Van Zandwijk N, Shepherd F, Ardizzoni A, Barton C, Ghahramani P, Hirsh V.
    Ann Oncol; 2004 Jan 15; 15(1):19-27. PubMed ID: 14679114
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. [Gemcitabine plus cisplatin versus gemcitabine plus vinorelbine in treatment of advanced non-small cell lung cancer (NSCLC)].
    Zhang L, Zhang Y, Li N, Xu F, Pan ZK, Guan ZZ.
    Ai Zheng; 2004 Nov 15; 23(11 Suppl):1455-8. PubMed ID: 15566656
    [Abstract] [Full Text] [Related]

  • 18. Randomized phase II study of carboplatin/gemcitabine versus vinorelbine/gemcitabine in patients with advanced nonsmall cell lung cancer: West Japan Thoracic Oncology Group (WJTOG) 0104.
    Yamamoto N, Nakagawa K, Uejima H, Sugiura T, Takada Y, Negoro S, Matsui K, Kashii T, Takada M, Nakanishi Y, Kato T, Fukuoka M, West Japan Thoracic Oncology Group (WJTOG).
    Cancer; 2006 Aug 01; 107(3):599-605. PubMed ID: 16804877
    [Abstract] [Full Text] [Related]

  • 19. Gemcitabine and cisplatin versus mitomycin, ifosfamide, and cisplatin in advanced non-small-cell lung cancer: A randomized phase III study of the Italian Lung Cancer Project.
    Crinò L, Scagliotti GV, Ricci S, De Marinis F, Rinaldi M, Gridelli C, Ceribelli A, Bianco R, Marangolo M, Di Costanzo F, Sassi M, Barni S, Ravaioli A, Adamo V, Portalone L, Cruciani G, Masotti A, Ferrara G, Gozzelino F, Tonato M.
    J Clin Oncol; 1999 Nov 01; 17(11):3522-30. PubMed ID: 10550150
    [Abstract] [Full Text] [Related]

  • 20. Prolonged gemcitabine infusion in advanced non-small cell lung carcinoma: a randomized phase II study of two different schedules in combination with cisplatin.
    Ceribelli A, Gridelli C, De Marinis F, Fabi A, Gamucci T, Cortesi E, Barduagni M, Antimi M, Maione P, Migliorino MR, Giannarelli D, Cognetti F.
    Cancer; 2003 Jul 15; 98(2):337-43. PubMed ID: 12872354
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 35.